Lincoln Pharmaceuticals informs about disclosure

07 Jun 2022 Evaluate

Lincoln Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Rajanbhai Patel & PACs.

The above information is a part of company’s filings submitted to BSE

Lincoln Pharma Share Price

615.80 -1.85 (-0.30%)
22-Nov-2024 11:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.05
Dr. Reddys Lab 1205.00
Cipla 1481.15
Lupin 2058.25
Zydus Lifesciences 943.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.